Literature DB >> 18644398

omega-Conotoxin inhibition of excitatory synaptic transmission evoked by dorsal root stimulation in rat superficial dorsal horn.

Leonid Motin1, David J Adams.   

Abstract

A number of omega-conotoxins are potent and selective antagonists of N-type voltage-gated calcium channels (VGCCs) and are potentially effective as analgesic agents. omega-Conotoxins CVID and CVIB, venom peptides from Conus catus, inhibit N-type and N/P/Q-type VGCCs, respectively, in rat dorsal root ganglion sensory neurons. In the present study, we tested the effects of five different omega-conotoxins, CVID, CVIB, MVIIA, MVIIC and GVIA, on excitatory synaptic transmission between primary afferents and dorsal horn superficial lamina neurons of rat spinal cord. The N-type VGCC antagonists CVID (200nM) and MVIIA (500nM) completely and irreversibly inhibited excitatory postsynaptic currents (EPSCs) in the dorsal horn superficial lamina. The N- and P/Q-type VGCC antagonist CVIB (200nM) reversibly reduced evoked EPSC amplitude an average of 34+/-8%, whereas MVIIC (200nM) had no effect on excitatory synaptic transmission. In neurons receiving polysynaptic input, CVIB reduced both the EPSC amplitude and the "success rate" calculated as the relative number of primary afferent stimulations that resulted in postsynaptic responses. These results indicate that (i) the analgesic action of omega-conotoxins that antagonise N-type VGCCs may be attributed to inhibition of neurotransmission between primary afferents and superficial dorsal horn neurons, (ii) nociceptive synaptic transmission between primary afferents and superficial lamina neurons is mediated predominantly by N-type VGCCs, and (iii) in contrast to the irreversible inhibition by CVID, MVIIA and GVIA, the inhibition of excitatory monosynaptic transmission by CVIB is reversible.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18644398     DOI: 10.1016/j.neuropharm.2008.06.049

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  13 in total

Review 1.  Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain.

Authors:  S Vink; P F Alewood
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

2.  Differential effects of voltage-gated calcium channel blockers on calcium channel alpha-2-delta-1 subunit protein-mediated nociception.

Authors:  E Chang; X Chen; M Kim; N Gong; S Bhatia; Z D Luo
Journal:  Eur J Pain       Date:  2014-08-27       Impact factor: 3.931

3.  Spinal actions of ω-conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model.

Authors:  A Jayamanne; H J Jeong; C I Schroeder; R J Lewis; M J Christie; C W Vaughan
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

4.  Identification of CaV channel types expressed in muscle afferent neurons.

Authors:  Renuka Ramachandra; Bassil Hassan; Stephanie G McGrew; James Dompor; Mohamed Farrag; Victor Ruiz-Velasco; Keith S Elmslie
Journal:  J Neurophysiol       Date:  2013-07-10       Impact factor: 2.714

5.  Regulation of spinal substance p release by intrathecal calcium channel blockade.

Authors:  Toshifumi Takasusuki; Tony L Yaksh
Journal:  Anesthesiology       Date:  2011-07       Impact factor: 7.892

6.  Presynaptic Cav3.2 channels regulate excitatory neurotransmission in nociceptive dorsal horn neurons.

Authors:  Megan O Jacus; Victor N Uebele; John J Renger; Slobodan M Todorovic
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

Review 7.  Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type (Ca(V) 2.2) calcium channels.

Authors:  David J Adams; Brid Callaghan; Géza Berecki
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 8.  Venom peptides as a rich source of cav2.2 channel blockers.

Authors:  Silmara R Sousa; Irina Vetter; Richard J Lewis
Journal:  Toxins (Basel)       Date:  2013-02-04       Impact factor: 4.546

9.  Novel ω-conotoxins from C. catus reverse signs of mouse inflammatory pain after systemic administration.

Authors:  Mahsa Sadeghi; Swetha S Murali; Richard J Lewis; Paul F Alewood; Sarasa Mohammadi; MacDonald J Christie
Journal:  Mol Pain       Date:  2013-10-20       Impact factor: 3.395

Review 10.  Omega-conotoxins as experimental tools and therapeutics in pain management.

Authors:  Heidi E Hannon; William D Atchison
Journal:  Mar Drugs       Date:  2013-03-07       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.